2007 annual financial data
Halozyme Therapeutics 2007 Revenue growth
Direct answer
Revenue growth was 287.02%.
Operating income was -28,150,207 USD and net income was -23,896,183 USD.
Operating cash flow was -147,660 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,799,521 USD
- Operating income
- -28,150,207 USD
- Net income
- -23,896,183 USD
- Operating cash flow
- -147,660 USD